Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease

Neuropsychopharmacology

Volumn 30, Issue 3, 2005, Pages 590-601

  Black, Kevin J ^a,b   Hershey, Tamara ^a   Hartlein, Johanna M ^a   Carl, Juanita L ^a   Perlmutter, Joel S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral blood flow; Cingulate gyrus; Levodopa; Mood disorders; Parkinson's disease; Positron emission tomography

Indexed keywords

CARBIDOPA; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; EMOTION; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MALE; MANIA; MOOD DISORDER; MOTOR PERFORMANCE; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AFFECT; ANTIPARKINSON AGENTS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE;

EID: 13944273811     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300632     Document Type: Article

References (88)

1. Baleydier C, Mauguiere F (1980). The duality of the cingulate gyrus in monkey. Neuroanatomical study and functional hypothesis. Brain 103: 525-554.
2. Baruzzi A, Contin M, Albani F, Riva R (1986). Simple and rapid micromethod for the determination of levodopa and 3-O-methyldopa in human plasma by high-performance liquid chromotography with coulometric detection. J Chromatogr B 375: 165-169.
3. Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T et al (2001). Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16: 1014-1022.
4. Black KJ, Carl JL, Hartlein JM, Warren SL, Hershey T, Perlmutter JS (2003). Rapid intravenous loading of levodopa for human research: clinical results. J Neurosci Methods 127: 19-29.
5. Black KJ, Gado MH, Perlmutter JS (1997). PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function. J Neurosci 17: 3168-3177.
6. 1 agonist activates temporal lobe structures in primates. J Neurophysiol 84: 549-557.
7. Black KJ, Hershey T, Koller JM, Carl JL, Perlmutter JS (2002a). Mapping and quantification of dopamine D2 receptor activation. J Neuropsychiatr Clin Neurosci 14: 118-119 (abstract).
8. Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL et al (2002b). A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci USA 99: 17113-17118.
9. Black KJ, Pandya A. Depression in Parkinson disease. In: Gilliam F, Sheline YI (eds). Depression and Brain Dysfunction. Parthenon Publishing: Oxon, UK (in press).
10. Brannan S, Liotti M, Egan G, Shade R, Madden L, Robillard R et al (2001). Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air. Proc Natl Acad Sci USA 98: 2029-2034.
11. Bremner JD, Narayan M, Staib LH, Southwick SM, McGlashan T, Charney DS (1999a). Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry 156: 1787-1795.
12. Bremner JD, Staib LH, Kaloupek D, Southwick SM, Soufer R, Charney DS (1999b). Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry 45: 806-816.
13. Bunney WE, Janowsky DS, Goodwin FK, Davis JM, Brodie HKH, Murphy DL et al (1969). Effect of L-dopa on depression. Lancet 1: 885-886.
14. Cantello R, Gilli M, Riccio A, Bergamasco B (1986). Mood changes associated with 'end-of-dose deterioration' in Parkinson's disease: a controlled study. J Neurol Neurosurg Psychiatry 49: 1182-1190.
15. Carl JL, Perlmutter JS (1998). A new method to measure L-DOPA & metabolites in plasma. Soc Neurosci Abstr 24: 352 (abstract).
16. Carter JH, Lyons KS, Stewart BJ, Archibald P (2002). Do the clinical features of Parkinson's disease explain spouse caregiver strain? Neurology 58: A468 (abstract).
17. Cotzias GC, van Woert HH, Schiffer LM (1967). Aromatic amino acids and modifications of parkinsonism. N Engl J Med 276: 374-379.
18. Cummings JL (1992). Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-454.
19. Damásio AR, Lobo-Antunes J, Macedo C (1971). Psychiatric aspects in Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry 34: 502-507.
20. Drevets WC (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11: 240-249.
21. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81-96.
22. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M et al (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
23. Duvoisin RC (1974). Variations in the on-off phenomenon. Adv Neurol 5: 339-340.
24. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ et al (2001). Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57: 2083-2088.
25. Folstein MF, Luria R (1973). Reliabiliy, validity, and clinical application of the visual analogue mood scale. Psychol Med 3: 479-486.
26. Friedenberg DL, Cummings JL (1989). Parkinson's disease, depression, and the on-off phenomenon. Psychosomatics 30: 94-99.
27. Fristen KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ (1995). Spatial registration and normalization of images. Hum Brain Mapp 2: 165-189.
28. Friston KJ, Grasby PM, Bench CJ, Frith CD, Cowen PJ, Liddle PF et al (1992). Measuring the neuromodulatory effects of drugs in man with positron emission tomography. Neurosci Lett 141: 106-110.
29. Goodwin FK (1990). Biochemical and pharmacological studies. In: Goodwin FK, Jamison KR (eds). Manic-Depressive Illness. Oxford University Press: New York, pp 416-502.
30. Grasby PM, Fristen KJ, Bench CJ, Cowen PJ, Frith CD, Liddle PF et al (1993). The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychol Med 23: 605-612.
31. Hardie RJ, Lees AJ, Stern GM (1984). On-off fluctuations in Parkinson's disease: a clinical and neuropharmacological study. Brain 107: 487-506.
32. 15O.I. Theory and error analysis. J Nucl Med 24: 782-789.
33. Hershey T, Black KJ, Carl JL, McGee-Minnich LA, Snyder AZ, Perlmutter JS (2003). Chronic treatment and disease severity alter brain responses to levodopa in PD. J Neurol Neurosurg Psychiatry 74: 844-851.
34. Hershey T, Black KJ, Carl JL, Perlmutter JS (2000). Dopa-induced blood flow responses in non-human primates. Exp Neurol 166: 342-349.
35. Hershey T, Black KJ, Stambuk MK, Carl JL, McGee-Minnich LA, Perlmutter JS (1998). Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proc Natl Acad Sci USA 95: 12016-12021.
36. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J (2002). Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. J Am Med Assoc 287: 455-463.
37. Hornykiewicz O (1963). Die Topische Lokalisation und das Verhalten von Noradrenalin und Dopamin in der Substantia Nigra des normalen und Parkinsonkranken Menschen. Wien Klin Wochenschr 75: 309-312.
38. Hudziak JJ, Heizer JE, Wetzel MW, Kessel KB, McGee B, Janca A et al (1993). The use of the DSM-III-R Checklist for initial diagnostic assessments. Compr Psychiatry 34: 375-383.
39. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA (1992). Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 115: 521-537.
40. Jouvent R, Abensour P, Bonnet AM, Widlocher D, Agid Y, Lhermitte F (1983). Antiparkinsonian and antidepressant effects of high doses of bromocriptine. J Affect Disord 5: 141-145.
41. 2O PET study in humans. Neurosci Lett 176: 21-24.
42. Keshavan MS, David AS, Narayanen HS, Satish P (1986). 'On-off' phenomena and manic-depressive mood shifts: case report. J Clin Psychiatry 47: 93-94.
43. Klimek V, Schenck J, Han H, Stockmeier C, Ordway G (2002). Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 52: 740-748.
44. Kostic VS, Lecic D, Doder M, Marinkovic J, Filipovic S (1996). Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Biol Psychiatry 40: 769-775.
45. Lees AJ (1989). The on-off phenomenon. J Neurol Neurosurg Psychiatry 52(Suppl): 29-37.
46. Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S et al (1999). Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 45: 817-826.
47. Liotti M, Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT (2000). Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 48: 30-42.
48. Lisanby SH, McDonald WM, Massey EW, Doraiswamy PM, Rozear M, Boyko OB et al (1993). Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm Suppl 40: 13-21.
49. Maddock RJ (1999). The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci 22: 310-316.
50. Malizia AL (1999). What do brain imaging studies tell us about anxiety disorders? J Psychopharmacol 13: 372-378.
51. Maricle RA, Nutt JG, Carter JH (1995a). Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Mov Disord 10: 329-332.
52. Maricle RA, Nutt JG, Valentine RJ, Carter JH (1995b). Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 45: 1757-1760.
53. Maricle RA, Valentine RJ, Carter J, Nutt JG (1998). Mood response to levodopa infusion in early Parkinson's disease. Neurology 50: 1890-1892.
54. Mayberg HS (1994). Frontal lobe dysfunction in secondary depression. J Neuropsychiatr Clin Neurosci 6: 428-442.
55. Mayberg HS (1997). Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatr Clin Neurosci 9: 471-481.
56. Mayberg HS (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65: 193-207.
57. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48: 830-843.
58. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675-682.
59. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF et al (1990). Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 28: 57-65.
60. Mayeux R, Stern Y, Williams JB, Cote L, Frantz A, Dyrenfurth I (1986). Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 143: 756-759.
61. Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J (1995). A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 2: 89-101.
62. McCulloch J, Kelly PA, Ford I (1982). Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab 2: 487-499.
63. Melamed E, Globus M, Mildworf B (1986). Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during 'on' and 'off' response fluctuations. J Neurol Neurosurg Psychiatry 49: 1301-1304.
64. Menza MA, Sage J, Marshall E, Cody R, Duvoisin R (1990). Mood changes and 'on-off' phenomena in Parkinson's disease. Mov Disord 5: 148-151.
65. Nissenbaum H, Quinn NP, Brown RG, Toone B, Gotham A-M, Marsden CD (1987). Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Psychol Med 17: 899-904.
66. Öngür D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
67. Öngür D, Price JL (2000). The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 10: 206-219.
68. Parvizi J, Van Hoesen GW, Buckwalter JV, Vianna E (2003). The neural connectivity of the retrosplenial cingulate cortex. Presented at the 14th Annual Meeting, American Neuropsychiatric Association, Honolulu, HI, 2 February 2003.
69. Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ (2002). Levodopa-related mood fluctuations in Parkinson's disease: clinical features and comorbidity. J Neuropsychiatr Clin Neurosci 14: 438-442.
70. 15O. II. Implementation and validation. J Nucl Med 24: 790-798.
71. Richard IH, Justus AW, Kurlan R (2001). Relationship between mood and motor fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13: 35-41.
72. Riley DE, Lang AE (1993). The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology 43: 1459-1464.
73. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RSJ, Dolan RJ (1994). Depression in Parkinson's disease: a positron emission study. Br J Psychiatry 165: 333-339.
74. Sheline YI, Mittler BL, Mintun MA (2002). The hippocampus and depression. Eur Psychiatry 17(Suppl 3): 300-305.
75. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996). Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908-3913.
76. Shin LM, Kosslyn SM, McNally RJ, Alpert NM, Thompson WL, Rauch SL et al (1997). Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry 54: 233-241.
77. Siemers ER, Shekhar A, Quaid K, Dickson H (1993). Anxiety and motor performance in Parkinson's disease. Mov Disord 8: 1-6.
78. Simpson Jr JR, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME (2001). Emotion-induced changes in human medial prefrontal cortex: II. during anticipatory anxiety. Proc Natl Acad Sci USA 98: 688-693.
79. Stefurak TL, New P, Mahurin RK, Soloman D, Brannan D, Mayberg H (2001). Response specific regional metabolic changes with fluoxetine treatment in depressed Parkinson's patients. Mov Disord 16(Suppl 1): S39 (abstract).
80. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Theime Verlag: New York.
81. Torack RM, Morris JC (1988). The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 45: 497-501.
82. Trugman JM, Wooten GF (1986). The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Res 379: 264-274.
83. Van Hoesen GW, Morecraft RJ, Vogt BA (1993). Connections of the monkey cingulate cortex. In: Vogt BA, Gabriel M (eds). Neurobiology of Cingulate Cortex and Limbic Thalamus: A Comprehensive Handbook. Birkhäuser: Boston, pp 249-284.
84. Vázquez A, Jiménez-Jiménez FJ, Garcia-Ruiz P, Garcia-Urra D (1993). 'Panic attacks' in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 87: 14-18.
85. Videen TO, Perlmutter JS, Herscovitch P, Raichle ME (1987). Brain blood volume, flow and oxygen utilization measured with O-15 radiotracers and positron emission tomography: revised metabolic computations. J Cereb Blood Flow Metab 7: 513-516.
86. Vogt BA, Hof PR, Vogt LJ (2003). Cingulate gyrus. In: Paxinos G, Mai JK (eds). The Human Nervous System, 2nd edn. Academic Press: San Diego, pp 915-949.
87. Vogt BA, Rosene DL, Pandya DN (1979). Thalamic and cortical afferents differentiate anterior from posterior cingulate cortex in the monkey. Science 204: 205-207.
88. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J et al (2002). Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59: 408-413.